WO2000079274A3 - Methods for assaying subcellular conditions using energy transfer - Google Patents

Methods for assaying subcellular conditions using energy transfer Download PDF

Info

Publication number
WO2000079274A3
WO2000079274A3 PCT/US2000/017380 US0017380W WO0079274A3 WO 2000079274 A3 WO2000079274 A3 WO 2000079274A3 US 0017380 W US0017380 W US 0017380W WO 0079274 A3 WO0079274 A3 WO 0079274A3
Authority
WO
WIPO (PCT)
Prior art keywords
energy transfer
methods
assaying
membrane potential
subcellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/017380
Other languages
French (fr)
Other versions
WO2000079274A2 (en
Inventor
James A Dykens
Gonul Velicelebi
Soumitra S Ghosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Migenix Corp
Original Assignee
Mitokor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/338,122 external-priority patent/US6323039B1/en
Application filed by Mitokor Inc filed Critical Mitokor Inc
Priority to JP2001505191A priority Critical patent/JP2003506014A/en
Priority to CA002375542A priority patent/CA2375542A1/en
Priority to EP00943119A priority patent/EP1210596A2/en
Priority to AU57636/00A priority patent/AU5763600A/en
Publication of WO2000079274A2 publication Critical patent/WO2000079274A2/en
Anticipated expiration legal-status Critical
Publication of WO2000079274A3 publication Critical patent/WO2000079274A3/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • G01N33/5079Mitochondria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

The invention provides compositions and methods for monitoring subcellular compartments such as organelles by energy transfer techniques that do not require specific intermolecular affinity binding events between energy transfer donor and energy transfer acceptor molecules. Provided are methods for assaying cellular membrane potential, including mitochondrial membrane potential, by energy transfer methodologies including fluorescence resonance energy transfer (FRET). Diagnostic and drug screening assays are also provided.
PCT/US2000/017380 1999-06-22 2000-06-22 Methods for assaying subcellular conditions using energy transfer Ceased WO2000079274A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2001505191A JP2003506014A (en) 1999-06-22 2000-06-22 Compositions and methods for assaying subcellular conditions and processes using energy transfer
CA002375542A CA2375542A1 (en) 1999-06-22 2000-06-22 Compositions and methods for assaying subcellular conditions and processes energy transfer
EP00943119A EP1210596A2 (en) 1999-06-22 2000-06-22 Methods for assaying subcellular conditions using energy transfer
AU57636/00A AU5763600A (en) 1999-06-22 2000-06-22 Compositions and methods for assaying subcellular conditions and processes usingenergy transfer

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US14043399P 1999-06-22 1999-06-22
US09/338,122 1999-06-22
US09/338,122 US6323039B1 (en) 1999-06-22 1999-06-22 Compositions and methods for assaying subcellular conditions and processes using energy transfer
US60/140,433 1999-06-22
US17638300P 2000-01-14 2000-01-14
US60/176,383 2000-01-14

Publications (2)

Publication Number Publication Date
WO2000079274A2 WO2000079274A2 (en) 2000-12-28
WO2000079274A3 true WO2000079274A3 (en) 2002-01-10

Family

ID=27385499

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/017380 Ceased WO2000079274A2 (en) 1999-06-22 2000-06-22 Methods for assaying subcellular conditions using energy transfer

Country Status (5)

Country Link
EP (1) EP1210596A2 (en)
JP (1) JP2003506014A (en)
AU (1) AU5763600A (en)
CA (1) CA2375542A1 (en)
WO (1) WO2000079274A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ296799A0 (en) 1999-09-20 1999-10-14 Unisearch Limited A cell-membrane impermeable trivalent organoarsenical derivative and use thereof
US6287758B1 (en) * 2000-03-23 2001-09-11 Axiom Biotechnologies, Inc. Methods of registering trans-membrane electric potentials
AUPR537101A0 (en) * 2001-05-31 2001-06-28 International Diabetes Institute A method of assessment and treatment
EP1423122A4 (en) * 2001-08-15 2008-12-10 Univ Michigan COMPOSITIONS AND METHODS RELATING TO NOVEL BENZODIAZEPINE COMPOUNDS AND TARGETS
CA2504935C (en) 2002-11-07 2012-04-10 Newsouth Innovations Pty Limited Induction of the mitochondrial permeability transition
JP4755587B2 (en) 2004-05-18 2011-08-24 田辺三菱製薬株式会社 Method for evaluating substances that change the membrane potential of mitochondria
JP5301449B2 (en) 2006-11-01 2013-09-25 ニューサウス イノベイションズ ピーティーワイ リミテッド Organic arsenoxide compounds and uses thereof
EP2395055A4 (en) 2009-02-06 2012-07-18 Univ Hokkaido Nat Univ Corp SOLVATOCHROME PIGMENT FLUORESCENT
KR20130079362A (en) * 2010-03-25 2013-07-10 내셔날 유니버시티 코포레이션 유니버시티 오브 토야마 Fluorescent probe for plasma cell identification and isolation, and plasma cell identification or isolation method using the probe
EP2995948A1 (en) * 2014-09-09 2016-03-16 Ecole Polytechnique Federale de Lausanne (EPFL) Methods and compounds useful in hematopoietic stem cell medicine
JP6958860B2 (en) * 2017-11-07 2021-11-02 学校法人自治医科大学 Agents for improving mitochondrial dysfunction, preventive or therapeutic agents for diseases or symptoms caused by mitochondrial dysfunction, and their uses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996041166A2 (en) * 1995-06-07 1996-12-19 The Regents Of The University Of California Detection of transmembrane potentials by optical methods

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996041166A2 (en) * 1995-06-07 1996-12-19 The Regents Of The University Of California Detection of transmembrane potentials by optical methods

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
CACCIATORE TIMOTHY W ET AL: "Identification of neural circuits by imaging coherent electrical activity with FRET-based dyes.", NEURON, vol. 23, no. 3, July 1999 (1999-07-01), pages 449 - 459, XP000961663, ISSN: 0896-6273 *
CORTESE JORGE D ET AL: "Novel fluorescence membrane fusion assays reveal GTP-dependent fusogenic properties of outer mitochondrial membrane-derived proteins.", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1371, no. 2, 28 May 1998 (1998-05-28), pages 185 - 198, XP000961685, ISSN: 0006-3002 *
DYKENS J A ET AL: "A FRET-based, whole-cell assay of mitochondrial membrane potential for drug screening.", SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 25, no. 1-2, 1999, 29th Annual Meeting of the Society for Neuroscience, Part 1;Miami Beach, Florida, USA; October 23-28, 1999, pages 282, XP000961632, ISSN: 0190-5295 *
GONZALEZ JESUS E ET AL: "Improved indicators of cell membrane potential that use fluorescence resonance energy transfer.", CHEMISTRY & BIOLOGY (LONDON), vol. 4, no. 4, 1997, pages 269 - 277, XP000961796, ISSN: 1074-5521 *
GONZALEZ JESUS E ET AL: "Voltage sensing by fluorescence resonance energy transfer in single cells.", BIOPHYSICAL JOURNAL, vol. 69, no. 4, 1995, pages 1272 - 1280, XP000961694, ISSN: 0006-3495 *
HUEGLIN D ET AL: "Time-resolved microfluorometric study of the binding sites of lipophilic cationic pyrene probes in mitochondria of living HeLa cells.", JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B BIOLOGY, vol. 31, no. 3, 1995, pages 145 - 158, XP000998251, ISSN: 1011-1344 *
LEMASTERS JOHN J ET AL: "The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy.", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1366, no. 1-2, 10 August 1998 (1998-08-10), pages 177 - 196, XP000961686, ISSN: 0006-3002 *
MAHAJAN N P ET AL: "BCL-2 AND BAX INTERACTIONS IN MITOCHONDRIA PROBED WITH GREEN FLUORESCENT PROTEIN AND FLUORESCENCE RESONANCE ENERGY TRANSFER", NATURE BIOTECHNOLOGY,US,NATURE PUBLISHING, vol. 16, June 1998 (1998-06-01), pages 547 - 552, XP000876894, ISSN: 1087-0156 *
RIZZUTO R ET AL: "DOUBLE LABELLING OF SUBCELLULAR STRUCTURES WITH ORGANELLE-TARGETED GFP MUTANTS IN VIVO", CURRENT BIOLOGY,GB,CURRENT SCIENCE,, vol. 6, no. 2, 1 February 1996 (1996-02-01), pages 183 - 188, XP000610252, ISSN: 0960-9822 *
USTER, PAUL S. ET AL: "Resonance energy transfer microscopy: observations of membrane-bound fluorescent probes in model membranes and in living cells", J. CELL BIOL. (1986), 103(4), 1221-34, XP000998288 *

Also Published As

Publication number Publication date
WO2000079274A2 (en) 2000-12-28
JP2003506014A (en) 2003-02-18
CA2375542A1 (en) 2000-12-28
AU5763600A (en) 2001-01-09
EP1210596A2 (en) 2002-06-05

Similar Documents

Publication Publication Date Title
WO2000079274A3 (en) Methods for assaying subcellular conditions using energy transfer
GB2477053A (en) Droplet-based System
WO2006002382A3 (en) Arrays with cleavable linkers
DE69933369D1 (en) Adressierbare protein arrays
CA2381344A1 (en) Optical system analysis of cells
ATE273956T1 (en) ARYL-SUBSTITUTED OLEFINIC AMINE AND THEIR USE AS CHOLINERGIC RECEPTOR AGONISTS
CA2362117A1 (en) A system for cell-based screening
PL328272A1 (en) Methods of and compositions for detecting ligand pair bonds using non-fluoroscent labelling
WO2005010215A3 (en) Methods for identifying tolerance modulatory compounds and uses therefor
WO2002046228A3 (en) Receptor for b. anthracis toxin
CA2328805A1 (en) Enzyme-protein complex
ATE207614T1 (en) FLUORESCENCE CORRELATION SPECTROSCOPY MODULE FOR A MICROSCOPE
TR200003390T2 (en) 2- (2-Methylphenyl) -3,4-dihydro-2H-pyrrole derivatives
WO2007035929A3 (en) Method for detecting and quantitating multiple subcellular components
EP2221385A3 (en) Deubiquination assays
TR200003389T2 (en) 2- (2-chlorophenyl) -3,4-dihydro-2H-pyrrole derivatives.
WO2000070342A3 (en) Optical system analysis of cells
CA2440399A1 (en) Epitope testing using hla
TR199901935T2 (en) Eprosartan haz�rlamak i�in process.
WO2004063339A3 (en) G-quadruplex binding assays and compounds therefor
IS5620A (en) Analytical methods
WO2006020263A3 (en) Cytoxan antibodies and immunoassay
TW200637830A (en) Erastin and erastin binding proteins, and uses thereof
TR200603433T1 (en) A cooler
WO2002095354A3 (en) Methods and labeled molecules for determining ligand binding to steroid receptors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 57636/00

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2375542

Country of ref document: CA

Ref country code: CA

Ref document number: 2375542

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 505191

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000943119

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2000943119

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000943119

Country of ref document: EP